[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588752":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":33,"responsibleParty":65,"collaborators":18,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":18,"enrollmentInfo":76,"targetDuration":18,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":18,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of Utah","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Precision Exercise Regimen for Cancer Care (PERCC)","EXPERIMENTAL","Participants will engage in PERCC starting at least two weeks prior to receiving their first neoadjuvant treatment for lung cancer and continuing until two months after receiving surgical treatment.",[13],"Other: Precision Exercise Regimen for Cancer Care (PERCC)",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":18},"PERCC has exercise modes including basic transfer and calisthenics mobility, aerobic, and resistance exercises, and will be performed in various postures (supine, sitting, standing, and walking) with variable challenges (level walking, bending, inclines, steps, and squatting). Each participant will complete one supervised, home-based exercise training session per week, delivered through telehealth, that will focus on the resistance exercise prescription. Other unsupervised exercise training sessions will focus on the aerobic exercise prescription and will be completed individually",[9],null,[20],{"name":21,"affiliation":22,"role":23},"Cornelia Ulrich, MS, PhD","Huntsman Cancer Institute\u002F University of Utah","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Thomas Varghese, MD, MS, MBA, FACS","CONTACT","801-581-5311","thomas.varghese@hsc.utah.edu",{"name":21,"role":27,"phone":31,"phoneExt":18,"email":32},"801-213-5716","neli.ulrich@hci.utah.edu",[34,53],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of Texas Medical Branch at Galveston","RECRUITING","Galveston","Texas","77555","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-94.7977,29.30135,{"lat":46,"lon":45},[49],{"name":50,"role":27,"phone":51,"phoneExt":18,"email":52},"Rebecca Geck, MSN\u002FMPH","409-266-0496","raschaef@utmb.edu",{"facility":54,"status":36,"city":55,"state":56,"zip":57,"country":40,"countryCode":41,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Huntsman Cancer Institute","Salt Lake City","Utah","84112",{"type":43,"coordinates":59},[60,61],-111.89105,40.76078,{"lat":61,"lon":60},[64],{"name":21,"role":27,"phone":18,"phoneExt":18,"email":32},{"type":66,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100588752","pilot-for-the-precision-exercise-regimen-for-cancer-care-percc-study-100588752",false,"NCT06945484","PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study","PILOT PERCC","Inclusion Criteria:\n\n* Ages 18 and older at time of diagnosis\n* Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)\n* Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery\n* Patient able to follow direction and complete questionnaires in English or Spanish\n* Patient agrees to complete the PERCC intervention\n\nExclusion Criteria:\n\n* Morbidly obese (BMI \\>40 kg\u002Fm2 ) or anorexic (BMI \\\u003C17.5 kg\u002Fm2 )\n* Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance\n* Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)\n* Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started","ALL","18 Years",{"count":77,"type":78},20,"ESTIMATED","INTERVENTIONAL",[81],"NA","This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.",[84,85],"NSCLC Stage II","NSCLC, Stage III","2026-01-30",{"date":88,"type":89},"2026-02-03","ACTUAL",{"date":91,"type":89},"2025-11-21",{"date":93,"type":78},"2030-12",{"name":5,"class":6},2]